To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05327647
Title A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer (BicaBCa)
Acronym BicaBCa
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
London Health Sciences Centre RECRUITING London Ontario N6A 5W9 Canada Details
University Health Network, Princess Margaret Cancer Centre RECRUITING Toronto Ontario M5G 2C1 Canada Details
Centre intégré de santé et services sociaux de Chaudière Appalaches RECRUITING Lévis Quebec G6V3Z1 Canada Details
Centre Hospitalier de l'Université De Montréal_CHUM RECRUITING Montréal Quebec H2X 3E4 Canada Details
McGill University Health Centre_CUSM RECRUITING Montréal Quebec H4A 3J1 Canada Details
CHU de Québec-Université Laval RECRUITING Québec Quebec G1G 5X1 Canada Details
CIUSSS de l'Estrie - CHUS RECRUITING Sherbrooke Quebec J1H 5H3 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field